Anti-ITA2B/ ITGA2B/ BDPLT16 monoclonal antibody
Anti-ITA2B/ ITGA2B/ BDPLT16 antibody for FACS & in-vivo assay
Go to ITGA2B/ITGA2B products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-TA029-Ab-1/ GM-Tg-hg-TA029-Ab-2 | Anti-Human ITGA2B monoclonal antibody | Human |
GM-Tg-rg-TA029-Ab-1/ GM-Tg-rg-TA029-Ab-2 | Anti-Rat ITGA2B monoclonal antibody | Rat |
GM-Tg-mg-TA029-Ab-1/ GM-Tg-mg-TA029-Ab-2 | Anti-Mouse ITGA2B monoclonal antibody | Mouse |
GM-Tg-cynog-TA029-Ab-1/ GM-Tg-cynog-TA029-Ab-2 | Anti-Cynomolgus/ Rhesus macaque ITGA2B monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-TA029-Ab-1/ GM-Tg-felg-TA029-Ab-2 | Anti-Feline ITGA2B monoclonal antibody | Feline |
GM-Tg-cang-TA029-Ab-1/ GM-Tg-cang-TA029-Ab-2 | Anti-Canine ITGA2B monoclonal antibody | Canine |
GM-Tg-bovg-TA029-Ab-1/ GM-Tg-bovg-TA029-Ab-2 | Anti-Bovine ITGA2B monoclonal antibody | Bovine |
GM-Tg-equg-TA029-Ab-1/ GM-Tg-equg-TA029-Ab-2 | Anti-Equine ITGA2B monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-TA029-Ab-1/ GM-Tg-hg-TA029-Ab-2; GM-Tg-rg-TA029-Ab-1/ GM-Tg-rg-TA029-Ab-2; GM-Tg-mg-TA029-Ab-1/ GM-Tg-mg-TA029-Ab-2; GM-Tg-cynog-TA029-Ab-1/ GM-Tg-cynog-TA029-Ab-2; GM-Tg-felg-TA029-Ab-1/ GM-Tg-felg-TA029-Ab-2; GM-Tg-cang-TA029-Ab-1/ GM-Tg-cang-TA029-Ab-2; GM-Tg-bovg-TA029-Ab-1/ GM-Tg-bovg-TA029-Ab-2; GM-Tg-equg-TA029-Ab-1/ GM-Tg-equg-TA029-Ab-2 |
Products Name | Anti-ITGA2B monoclonal antibody |
Format | mab |
Target Name | ITGA2B |
Protein Sub-location | Transmembrane Protein |
Category of antibody | FACS/Biofunctional Antibody, Therapeutics Target antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-ITGA2B benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Target information
Target ID | GM-TA029 |
Target Name | ITGA2B |
Gene ID | 3674,16399,685269,714955,403789,101100930,515011,100009697 |
Gene Symbol and Synonyms | alphaIIb,BDPLT16,BDPLT2,CD41,CD41B,GP2B,GPIIb,GT,GT1,GTA,HPA3,ITGA2B,PPP1R93 |
Uniprot Accession | P08514 |
Uniprot Entry Name | ITA2B_HUMAN |
Protein Sub-location | Transmembrane Protein |
Category | Therapeutics Target, INN Index |
Disease | N/A |
Gene Ensembl | ENSG00000005961 |
Target Classification | N/A |
The target: ITGA2B, gene name: ITGA2B, also named as BDPLT16, BDPLT2, CD41, CD41B, GP2B, GPIIb, GT, GTA, HPA3, PPP1R93. This gene encodes a member of the integrin alpha chain family of proteins. The encoded preproprotein is proteolytically processed to generate light and heavy chains that associate through disulfide linkages to form a subunit of the alpha-IIb/beta-3 integrin cell adhesion receptor. This receptor plays a crucial role in the blood coagulation system, by mediating platelet aggregation. Mutations in this gene are associated with platelet-type bleeding disorders, which are characterized by a failure of platelet aggregation, including Glanzmann thrombasthenia. [provided by RefSeq, Jan 2016].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.